FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Trade off: Ischemic/Thrombotic vs Bleeding
Renato D. Lopes, MD, MHS, PhD
Patient Case Study: Obesity
Valeria Caso, MD, PhD
Patient Case Study: Elderly
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Patient Case Study: Obesity and VTE
Alexander T. Cohen, MD, MBBS
Patient Case Study: Cancer-Associated Thrombosis
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Optimizing AAV Outcomes: Maintenance Therapies
Elevating Care for Patients With Severe Renal Disease in AAV
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Managing Patients With AAV in the Rheumatology Clinic
Implementing the SOC Induction Therapies in AAV
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.